BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21531207)

  • 1. Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin.
    Saito S; Lasky JA; Guo W; Nguyen H; Mai A; Danchuk S; Sullivan DE; Shan B
    Biochem Biophys Res Commun; 2011 May; 408(4):630-4. PubMed ID: 21531207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
    Yu J; Ma Z; Shetty S; Ma M; Fu J
    Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
    Asthana J; Kapoor S; Mohan R; Panda D
    J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6.
    Borgas D; Chambers E; Newton J; Ko J; Rivera S; Rounds S; Lu Q
    Am J Respir Cell Mol Biol; 2016 May; 54(5):683-96. PubMed ID: 26452072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.
    Joshi AD; Barabutis N; Birmpas C; Dimitropoulou C; Thangjam G; Cherian-Shaw M; Dennison J; Catravas JD
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1410-9. PubMed ID: 26498249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
    Zhang D; Wu CT; Qi X; Meijering RA; Hoogstra-Berends F; Tadevosyan A; Cubukcuoglu Deniz G; Durdu S; Akar AR; Sibon OC; Nattel S; Henning RH; Brundel BJ
    Circulation; 2014 Jan; 129(3):346-58. PubMed ID: 24146251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 6 inhibits influenza A virus release by downregulating the trafficking of viral components to the plasma membrane via its substrate, acetylated microtubules.
    Husain M; Cheung CY
    J Virol; 2014 Oct; 88(19):11229-39. PubMed ID: 25031336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
    Gold WA; Lacina TA; Cantrill LC; Christodoulou J
    J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation.
    Haggarty SJ; Koeller KM; Wong JC; Grozinger CM; Schreiber SL
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4389-94. PubMed ID: 12677000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
    Noack M; Leyk J; Richter-Landsberg C
    Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxol alleviates 2-methoxyestradiol-induced endothelial permeability.
    Gorshkov BA; Zemskova MA; Verin AD; Bogatcheva NV
    Vascul Pharmacol; 2012; 56(1-2):56-63. PubMed ID: 22074808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 is a microtubule-associated deacetylase.
    Hubbert C; Guardiola A; Shao R; Kawaguchi Y; Ito A; Nixon A; Yoshida M; Wang XF; Yao TP
    Nature; 2002 May; 417(6887):455-8. PubMed ID: 12024216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
    Skoge RH; Ziegler M
    J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6.
    Zilberman Y; Ballestrem C; Carramusa L; Mazitschek R; Khochbin S; Bershadsky A
    J Cell Sci; 2009 Oct; 122(Pt 19):3531-41. PubMed ID: 19737819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin.
    Zhao Z; Xu H; Gong W
    Protein Pept Lett; 2010 May; 17(5):555-8. PubMed ID: 19961433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
    Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
    J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystathionine γ-lyase protects vascular endothelium: a role for inhibition of histone deacetylase 6.
    Leucker TM; Nomura Y; Kim JH; Bhatta A; Wang V; Wecker A; Jandu S; Santhanam L; Berkowitz D; Romer L; Pandey D
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H711-H720. PubMed ID: 28188215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.
    Liu W; Fan LX; Zhou X; Sweeney WE; Avner ED; Li X
    PLoS One; 2012; 7(11):e49418. PubMed ID: 23152903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation.
    Nam HJ; Kang JK; Kim SK; Ahn KJ; Seok H; Park SJ; Chang JS; Pothoulakis C; Lamont JT; Kim H
    J Biol Chem; 2010 Oct; 285(43):32888-32896. PubMed ID: 20696758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition.
    Çetin Ö; Sari S; Erdem-Yurter H; Bora G
    Drug Dev Res; 2022 Jun; 83(4):993-1002. PubMed ID: 35266183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.